2016-03-10T00:00:00.000-05:00
lead product candidate,0.222538
email newsletter,0.566987
specialty pharmaceutical company,-0.272242
52-week low,-0.718025
quarterly earnings results,-0.281574
share,-0.226884
stock,-0.129395
Monday,-0.281574
development-stage specialty,-0.272242
AcelRx Pharmaceuticals,-0.00518304
52-week high,-0.718025
email address,0.505807
related companies,0.566987
report,0.212816
InvestorPlace Broker Center,0.555736
high fees,-0.735674
sell rating,0.406456
personal trading style,0.598412
Zacks Investment Research,0.446641
moderate-to-severe acute pain,-0.576865
investment analyst,0.406456
latest news,0.505807
Roth Capital,0.0972966
average rating,-0.455471
Pharmaceuticals Inc Daily,0.397938
research offerings,0.40995
average price,0.441468
adult patients,-0.576865
concise daily summary,0.505807
average target price,-0.379113
prior forecast,-0.304299
stock broker,0.245696
rating,-0.145835
